Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 22, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the
Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 11, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the
Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 1, 2024 / Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the de
6-K: Report of foreign private issuer (related to financial reporting)
Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
Biophytis to receive upfront and milestones payments for a total amount up to €108 million, as well as double-digit royaltieson future sales of the productAgreement covers commercialization of BIO101
Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities
Important note: Biophytis has set up financing in the form of Bonds redeemable in cash and in new and existing shares (ORNANE) with the company Atlas, which, after having received the shares resulting
Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by Its Service Provider Seqens
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / June 12, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of
Biophytis Announces Filing of an IND Application With the US FDA for Its Phase 2 Study in Obesity
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of
Combined General Meeting of June 24, 2024
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the deve
Biophytis Announces the Design of Its Phase 2 OBA Clinical Study in Obesity
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the deve
Biophytis Is Deploying Its Partnership Strategy in Obesity
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 29, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the de
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist
Top Premarket Decliners
Biophytis (BPTS) shares slumped 15% Thursday premarket after the company said it will transfer its American Depositary Shares listing to the OTC Markets. Meta Platforms (META) shares retreated nearly
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Teradyne, Inc. (NASDAQ:TER) rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued strong second-quarter forecast.Teradyne posted adjuste
Biophytis Announces Transfer of ADSs to OTC Market
ADSs delisted from Nasdaq, which will result in meaningful savingsADSs transferred to OTC Pink market; Company will apply to trade on OTCQB marketBiophytis remains listed on Euronext Growth Paris as its primary trading
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
No Data